-
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
-
Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk
-
Clin Mol Hepatol. 2021;27(1):110-124. Published online December 3, 2020
-
-
- Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
-
Emerging medical therapies for severe alcoholic hepatitis
-
David Tornai, Gyongyi Szabo
-
Clin Mol Hepatol. 2020;26(4):686-696. Published online September 28, 2020
-
-
- Review
-
Microbiome-Centered Therapies for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
-
Huma Saeed, Luis Antonio Díaz, Antonio Gil-Gómez, Jeremy Burton, Jasmohan Bajaj, Manuel Romero-Gomez, Marco Arrese, Juan Pablo Arab, Mohammad Qasim Khan
-
Received September 13, 2024 Accepted November 20, 2024
-
-
-
Unveiling the Intratumor Microbiome in Liver Cancer: Current Insights and Prospective Applications
-
Xindi Ke, Shangze Jiang, Qiaoxin Wei, Minghao Sun, Hang Sun, Mingchang Pang, Mei Liu, Lejia Sun, Huayu Yang, Yilei Mao
-
Received November 19, 2024 Accepted January 20, 2025
-
-
View: 391
Download: 46
|